Luma Health

Luma Health Competitive Intelligence & Landscape

lumahealth.io ·

Overview

Luma Health Overview

Luma Health is a healthcare technology company founded in 2015 and headquartered in San Mateo, California. The company specializes in providing an AI-native Patient Success Platform™ designed to streamline patient engagement and automate patient journeys for health systems, Federally Qualified Health Centers (FQHCs), and specialty practices (Exa). Its platform helps healthcare organizations improve access to care, reduce manual work for staff, and enhance patient outcomes by integrating deeply with electronic health records (EHRs) and leveraging advanced AI capabilities (Exa).

Luma Health serves over 650 healthcare organizations nationwide and has grown to a team of approximately 171 employees, with consistent year-over-year growth (+6.9%) (Exa). The company's core mission is to make healthcare easier for patients to access and for providers to manage, emphasizing speed, efficiency, and patient success. It has secured significant funding, totaling over USD 159 million, and continues to expand its impact, notably aiming to serve more than half of the US population by 2026 through its advanced Operational AI platform (PRNewswire).

Luma Health

Luma Health Weekly Intel Updates

Receive weekly intel updates about Luma Health straight to your inbox.

Competitors

Luma Health Competitors

Lumeon is a care orchestration platform that focuses on eliminating gaps in care through comprehensive care management and automation, making it distinct from Luma Health's patient engagement focus (softwarefinder). It targets large healthcare organizations seeking integrated care workflows, whereas Luma Health emphasizes automating patient communications and reducing no-shows (softwarefinder).

Klara Health offers a patient communication platform with a strong emphasis on real-time messaging, appointment scheduling, and telehealth, positioning itself as a user-friendly, easy-to-implement solution ideal for small to medium practices (softwarefinder). Compared to Luma, Klara is often praised for its simplicity and lower learning curve, though it may lack some of Luma’s advanced automation features and integrations (DemandHub).

Phreesia is a comprehensive patient intake and engagement platform that excels in automating check-in processes, insurance verification, and payment collection, making it a strong competitor for practices prioritizing operational efficiency (softwarefinder). It tends to be more expensive but offers a broader suite of operational tools, whereas Luma primarily focuses on communication and engagement automation (Toolradar).

Tebra (formerly Kareo) combines practice management, billing, and patient engagement in a single platform, targeting small to mid-sized practices seeking an all-in-one solution (softwarefinder). It offers extensive billing and revenue cycle management features, which differentiate it from Luma’s more communication-centric approach, and is generally positioned as a cost-effective, integrated solution (DemandHub).

Epic EMR and PrognoCIS EHR are more comprehensive electronic health record systems with built-in patient engagement modules, targeting larger healthcare providers and health systems. While they offer robust features, they tend to be more complex and costly compared to Luma, which is designed for ease of use and quick deployment for growing practices (softwarefinder).

Product & Pricing

Luma Health Product and Pricing Intelligence

Luma Health offers a patient engagement solution designed to streamline the healthcare process and enhance communication between providers and patients (SaaSCounter). The platform integrates with healthcare systems to improve operational efficiency and patient outcomes, featuring tools such as automated reminders, online booking, patient self-scheduling, two-way text messaging, and telehealth integration (SaaSCounter).

Luma Health also provides features like HIPAA compliance, customizable templates, and analytics and reporting to support healthcare providers (SaaSCounter).

The pricing for Luma Health is not publicly disclosed and is offered on a customized, quote-based model (Curogram). Potential clients must consult with a sales representative who will assess the practice's size, patient volume, required features, and the complexity of EHR integration to determine the final cost (Curogram). Some sources suggest a starting point of approximately $250 per user per month, though this is not a fixed price (Curogram). This bespoke approach ensures that healthcare providers pay for a solution tailored to their specific needs (Curogram).

In contrast to Luma Health's customized pricing, other Luma products, such as Luma Labs and Luma, offer more transparent pricing tiers.

Luma Labs provides individual plans like Plus ($30/month), Pro ($90/month), and Ultra ($300/month), with business plans like Team and Enterprise available upon contact (Luma).

Luma offers a free tier with unlimited events and guests, and a paid Luma Plus plan at $59 per month (billed annually), which includes features like a 0% platform fee for paid events and increased invite sends (Luma). Recent pricing changes for these Luma products are not detailed in the provided search results.

Ad Campaigns

Luma Health Ad Campaigns

Luma Health is currently running 229 ads across Google, LinkedIn — 72 on Google and 157 on LinkedIn. Explore Luma Health's live ad creative, messaging, and the platforms they advertise on in the ad library — updated automatically by ForesightIQ.

See of Luma Health's ads

View ads

Hiring & Layoffs

Luma Health Hiring and Layoffs

Recent hiring trends at Luma Health indicate a strong focus on expanding their leadership team to accelerate growth and AI development. Notably, the company appointed Puneet Arora as Chief Growth Officer in March 2026, aiming to scale their Operational AI platform to serve more than half of the US population by the end of 2026 (PR Newswire). This strategic hire underscores their emphasis on AI-driven healthcare solutions and market expansion. Additionally, Michael Chou joined as SVP of Product in January 2026, bringing extensive experience to accelerate AI innovation and product development (PR Newswire).

In terms of job openings, Luma Health has listed various roles across the US, including positions in customer success, sales, and product development, reflecting ongoing hiring efforts to support their growth and operational scale (LinkedIn). The company's hiring patterns demonstrate a strategy focused on expanding technical capabilities, customer success, and leadership to sustain their rapid growth and AI deployment. As of March 2026, there are no publicly reported layoffs, suggesting a positive outlook and continued investment in talent to meet their ambitious expansion goals (Built In). Overall, Luma's hiring trends and leadership appointments signal a strategic emphasis on AI innovation, market penetration, and organizational growth to solidify their position in healthcare technology.

Leadership

Luma Health Management and Leadership Team

As of March 2026, Luma Health is led by a strong executive team focused on healthcare IT innovation and operational AI solutions. The CEO, Adnan Iqbal, is a prominent figure with a background in R&D, finance, and strategy at Genentech, and he co-founded the company to improve patient access and healthcare efficiency (Forbes). The leadership team also includes Aditya Bansod as Chief Technology Officer, Tashfeen Ekram as Chief Medical Officer, Dave Smith as SVP of Revenue, and Marcelo Oliveira as SVP of R&D (The Org). Recent leadership changes include the appointment of Michael Chou as SVP of Product, tasked with accelerating AI development, and Puneet Arora as Chief Growth Officer, responsible for expanding the company's operational AI services to serve over half of the US population by 2026 (PR Newswire, Third News). Notable hires at the C-suite level include these strategic additions aimed at scaling Luma's healthcare AI platform and broadening its market reach.

Financials

Luma Health Financial Performance, Fundraising, M&A

As of early 2026, Luma Health has demonstrated strong financial growth and investment activity. The company has raised a total of approximately $159.1 million in funding, reflecting significant investor confidence (Tracxn). Its estimated annual revenue is around $29.5 million, with a revenue per employee of about $150,500, indicating a healthy financial position (CompWorth). The company’s valuation is not publicly disclosed, but its substantial funding and revenue figures suggest a strong market presence in healthcare technology (Growjo).

Luma Health is privately held and continues to expand its operations, with a current employee count of over 100 employees, reflecting a 14% growth rate over the past year (CompWorth). The company is also actively involved in international expansion and customer impact, serving more than 100 million patients across the U.S. and entering new markets such as the UK, Canada, and the Caribbean (PR Newswire). Overall, Luma Health’s financial health appears robust, backed by strong funding rounds, revenue growth, and strategic market expansion activities.

Partnerships

Luma Health Partnerships, Clients and Vendors

Luma Health is a prominent player in the patient engagement and relationship management sector, serving a substantial number of healthcare organizations. The company partners with various entities to streamline care access and enhance patient communication across the entire care journey.

Luma Health reports serving over 600 health systems, integrated delivery networks, federally qualified health centers, and specialty networks, demonstrating a broad reach within the healthcare industry (MEDITECH).

Notable partnerships for Luma Health include its collaboration with the Michigan Primary Care Association (MPCA). This partnership aims to modernize and accelerate care access for over 709,000 patients across 45 community health centers in Michigan, offering enhanced telehealth and multilingual text messaging outreach capabilities (Luma Health). Additionally, Luma Health has partnered with athenahealth, Inc. through its Marketplace program. This integration makes Luma Health's patient engagement solutions available to athenahealth's network of 120,000 healthcare providers, enabling them to better engage with patients throughout their care journey (Luma Health).

These collaborations highlight Luma Health's strategy to integrate its technology within existing healthcare ecosystems, such as with MEDITECH and athenahealth, to improve patient engagement and operational efficiency. The company's focus on total patient engagement and its operational AI aim to save significant hours in healthcare operations, with a reported saving of over 2 million hours by 2025 (Luma Health).

Events

Luma Health Event Participations

Luma Health actively participates in a variety of healthcare industry events, including conferences, trade shows, webinars, and community events. Notably, they hosted the HealthTech Summit 2026, which is part of SF HealthTech Week and coincides with the JPMorgan Healthcare Conference, showcasing their engagement in major industry gatherings (luma.com). Additionally, they organized the AI Healthcare Conference at Stanford, highlighting their involvement in academic and innovative healthcare discussions (luma.com).

Luma Health also sponsors and attends the HLTH 2025 event through their Innovation X Health Partner Program, emphasizing their commitment to industry networking and partnership development (luma.com). Furthermore, they participate in annual conferences such as Lumanate 2023, where healthcare leaders share strategies for patient empowerment, demonstrating their focus on thought leadership and community engagement (lumahealth.io).

Recent updates also indicate that Luma Health hosts webinars and community events to foster industry dialogue and showcase their operational AI solutions, such as their recent event celebrating their growth and innovations in healthcare workflows (luma.com). Overall, Luma Health's participation in these events underscores their active role in shaping healthcare technology and community collaboration in 2026.

Frequently Asked Questions

What does Luma Health's back-to-back C-suite hires in early 2026 signal about where they are in their growth cycle?

Luma Health appears to be entering an aggressive commercialization phase rather than a product-building one. In January 2026 they hired Michael Chou as SVP of Product to accelerate AI development, and in March 2026 they added Puneet Arora as Chief Growth Officer explicitly tasked with scaling the Operational AI platform to serve more than half the US population by end of 2026. Hiring both a product accelerator and a dedicated growth executive in rapid succession suggests the core platform is mature enough to scale and that the company is now prioritizing distribution and market penetration over foundational R&D.

Is Luma Health's $159M in total funding efficient relative to its ~$29.5M in annual revenue, and what does that ratio imply for an acquirer?

At roughly $29.5M in estimated annual revenue against $159.1M in total funding raised, Luma Health's capital efficiency ratio is approximately 5.4x — meaning it has consumed about $5.40 in investor capital for every $1 of annual revenue, which is elevated for a company of this stage and warrants scrutiny from a corp-dev perspective. The ~$150,500 revenue-per-employee figure indicates reasonable productivity for a 171-person team, but the gap between cumulative capital deployed and current revenue suggests heavy early investment in platform infrastructure and market development. An acquirer would need to assess whether the remaining runway and the Operational AI buildout can close that gap meaningfully before the next capital event.

What does Luma Health's partnership with athenahealth's Marketplace signal about their go-to-market strategy?

The athenahealth Marketplace partnership is a clear signal that Luma Health is pursuing an embedded distribution model — positioning its patient engagement layer inside the EHR ecosystems where healthcare providers already live, rather than selling standalone. Access to athenahealth's network of 120,000 healthcare providers dramatically expands Luma's addressable reach without proportional sales headcount. Combined with integrations cited alongside MEDITECH, this pattern suggests Luma is betting that deep EHR interoperability is a durable moat against competitors like Klara and Phreesia who may lack equivalent integration depth.

What does Luma Health's Michigan Primary Care Association deal reveal about their target segment priorities?

The MPCA partnership — covering 709,000 patients across 45 community health centers — signals that Federally Qualified Health Centers and safety-net providers are a deliberate segment focus, not an opportunistic win. Luma specifically highlighted multilingual text messaging outreach capabilities in the announcement, which is a differentiator required in FQHC environments with diverse, underserved populations. This suggests Luma is building product features (multilingual communication, telehealth access) specifically to win and retain mission-driven health centers, a segment that tends to prioritize affordability and equity metrics alongside operational efficiency.

How does Luma Health's competitive positioning against Phreesia and Epic's built-in modules hold up as health systems consolidate?

Luma Health's core differentiation — ease of deployment, communication automation, and AI-driven patient engagement — is most defensible in mid-market health systems, FQHCs, and specialty networks that cannot absorb the cost and complexity of Epic's native modules or Phreesia's broader operational suite. As health system consolidation pushes more organizations onto Epic, Luma faces structural pressure unless its EHR integration layer remains seamless and its AI features deliver measurably better outcomes than what Epic offers natively. The company's reported saving of over 2 million staff hours by 2025 is the kind of ROI metric that needs to be front-and-center to justify a third-party engagement layer alongside an enterprise EHR.

Luma Health is hosting and co-hosting major events including HealthTech Summit 2026 and an AI Healthcare Conference at Stanford — what does this event strategy suggest about their BD ambitions?

Organizing or co-organizing events at the level of SF HealthTech Week (which coincides with the JPMorgan Healthcare Conference) and an AI-focused conference at Stanford indicates Luma Health is actively positioning itself as a thought-leadership platform, not just a vendor. This is a classic top-of-funnel strategy for enterprise and health-system deals where trust and visibility among C-suite buyers matter. Sponsoring HLTH 2025 through an Innovation X Health Partner Program further suggests they are investing in ecosystem relationships — which often precede larger partnership and distribution announcements.

Does Luma Health's headcount growth and hiring pattern suggest it is on a path to profitability or still in investment mode?

Luma Health's approximately 171-person team with reported 6.9–14% year-over-year headcount growth, combined with no publicly reported layoffs as of March 2026, points to a company still in investment mode rather than optimizing for near-term profitability. The simultaneous addition of a Chief Growth Officer and SVP of Product in early 2026, alongside open roles in customer success, sales, and product, reflects a deliberate spend-to-grow strategy. Given total funding of $159.1M and estimated revenue of $29.5M, it is unlikely the company is cash-flow positive, though exact burn rate is not publicly disclosed.

What does the framing of Luma Health's platform as 'Operational AI' rather than 'patient engagement' tell us about how they are repositioning competitively?

The deliberate shift to 'Operational AI' branding — reflected in the Chief Growth Officer hire announcement and internal communications — signals that Luma is moving up the value chain from point-solution messaging tool to a workflow orchestration platform. Patient engagement is a commoditizing category with low switching costs; operational AI that integrates deeply with EHRs and automates administrative workflows is a stickier, higher-ASP proposition. This repositioning is likely a direct competitive response to Lumeon (care orchestration) and Phreesia (operational breadth), and positions Luma for larger enterprise deals and a higher valuation multiple if they pursue a future liquidity event.

With Luma Health targeting 'more than half the US population' served by end of 2026, how credible is that goal given their current scale?

The claim is aspirational and should be read as a directional market signal rather than a hard operational target. Luma currently serves over 650 healthcare organizations and reports reaching more than 100 million patients — a substantial base, but well below the ~165 million people that would constitute half the US population. The athenahealth Marketplace integration (120,000 providers) and partnerships like MPCA are the mechanisms most likely to drive rapid patient-reach expansion without linear headcount growth. The appointment of Puneet Arora specifically to pursue this goal suggests leadership is treating it as a measurable OKR, but independent verification of patient-reach methodology would be needed before taking the figure at face value.

What does Luma Health's quote-based, non-public pricing model imply about their sales motion and competitive vulnerability?

A fully opaque, quote-based pricing model — with only an approximate $250/user/month starting point cited in third-party sources — indicates Luma is running a high-touch enterprise sales motion where deal size, EHR complexity, and patient volume drive significant price variation. This approach protects margin on larger accounts but creates competitive vulnerability against alternatives like Klara that market simpler, more transparent pricing to smaller practices. For corp-dev purposes, the lack of disclosed pricing also makes ARR and net revenue retention estimation difficult, increasing due diligence complexity.

CEO Adnan Iqbal's background is in R&D, finance, and strategy at Genentech — how does that shape Luma Health's strategic identity?

A founder-CEO with Genentech experience in R&D and strategy rather than a pure software or enterprise-sales background suggests Luma Health was built with a clinical and outcomes orientation from the start, which aligns with its focus on patient success rather than purely administrative efficiency. That background also likely influences the company's credibility with health-system and FQHC buyers who are skeptical of pure-play tech vendors. On the other hand, a company at Luma's revenue scale ($29.5M) and growth ambition (half the US population by 2026) may eventually need sales-native executive leadership at the CEO level to execute the commercial intensity that target implies.

Luma Health has expanded into the UK, Canada, and the Caribbean — what strategic risk does international expansion introduce at this stage?

International expansion into the UK, Canada, and the Caribbean at a ~171-person headcount and ~$29.5M revenue level introduces meaningful execution risk: each market has distinct EHR ecosystems, regulatory frameworks (GDPR in the UK, PHIPA in Canada), and reimbursement models that require localized product and compliance investment. For a company still in investment mode and racing to serve half the US population, geographic diversification competes for the same engineering, compliance, and customer success resources. Unless international markets are being pursued opportunistically through existing partner channels rather than direct sales infrastructure, this expansion could dilute focus at a critical domestic scaling moment.

Powered by ForesightIQ · Competitive intelligence from digital exhaust